Loading...

B. Joseph Guglielmo, PharmD

TitleDean, School of Pharmacy
SchoolUCSF School of Pharmacy
DepartmentDean's Office
Address513 Parnassus Avenue
San Francisco CA 94117
Phone415-476-8010
vCardDownload vCard
    Other Positions
    TitleProfessor of Clinical Pharmacy
    InstitutionUCSF School of Pharmacy
    DepartmentDean's Office


    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency 1979School of Pharmacy - Pharmacy Practice
    University of Southern California (USC)PharmD1978Pharmacy
    Santa Clara UniversityB.S.1973Biology
    Collapse Awards and Honors
    UCSF1981Long Foundation Award for Excellence in Teaching
    UCSF1981Pharmacy Residents Preceptorship Award
    UCSF1985Pharmacy Residents Preceptorship Award
    UCSF1986Long Foundation Award for Excellence in Teaching
    UCSF1987Pharmacy Residents Preceptorship Award
    UCSF1989Pharmacy Residents Preceptorship Award
    UCSF1988Pharmacy Residents Preceptorship Award
    UCSF1992Academic Senate Distinction in Teaching Award
    UCSF1992Commencement Speaker, School of Pharmacy
    California Society of Health-System Pharmacists1993Fellow
    Phi Lambda Sigma1995Pharmacy Leadership Society Recognition
    UCSF1995Pharmacy Residents Preceptorship Award
    UCSF1999Long Prize for Excellence in Teaching
    UCSF2005Vincent G. Pons Award in Clinical Infectious Diseases
    UCSF2010Faculty Mentoring Program Lifetime Achievement in Mentoring Award
    American College of Clinical Pharmacy2011Fellow
    UCSF2013Troy C. Daniels Distinguished Professorship in Pharmaceutical Science

    Collapse Overview 
    Collapse Overview
    B. Joseph Guglielmo, PharmD, is a pharmacist, clinical scientist, teacher, and international expert in the evidence-based use of antimicrobials to treat infections. He has served as interim dean, then as dean of the UCSF School of Pharmacy, since 2012 and holds the Troy C. Daniels Distinguished Professorship in Pharmaceutical Sciences.

    He is widely known as an advocate for therapeutics-related research, from basic science to health policy research. As chair of the School's Department of Clinical Pharmacy, Guglielmo oversaw a 40 percent increase in the Department of Clinical Pharmacy’s faculty research funding from 2006 to 2012, including grants from the National Institutes of Health. During that period an increasing number of the department’s clinical faculty members received National Institutes of Health “K” awards, designed to develop clinical research scientists as independent investigators, as well as “R” awards that fund specific research projects.

    He created the Department of Clinical Pharmacy-run Medication Outcomes Center in 2007 to research and improve medication use in the UCSF Medical Center and beyond. In the 1980s he developed the UCSF Medical Center Antimicrobial Stewardship Program to study and improve antimicrobial use in the UCSF Medical Center, with the goal of decreasing antimicrobial resistance. This evidence-based program was one of the earliest programs of its kind in the United States.

    As patients seek new and cost-effective health care with increasingly complicated disease states and medications, Guglielmo advocates for research on new ways for pharmacists to care for patients, especially in the community. He also supports strong relationships among clinical scientists and their upstream basic and translational scientist colleagues, as demonstrated through his own collaborations. Guglielmo has been actively involved in the UCSF Clinical and Translational Science Institute (CTSI) from its inception and during its renewal; he has also served as the long-term associate director of the CTSI Mentor Development Program.

    His personal research agenda involves the safe, effective, and appropriate use of antimicrobials, as well as the pharmacoepidemiology and pharmacokinetics of anti-infective agents. He is the author of more than 110 peer-reviewed papers, the majority related to anti-infective agents.

    He believes that the most important clinical research is shaped through the researcher’s own clinical experiences. Together with his administrative, research, and teaching responsibilities, he practices in the UCSF Medical Center, where he is an infectious diseases pharmacist supporting the UCSF Medical Center Antimicrobial Stewardship Program and serving on the Infectious Diseases Consult Service team. These experiences continue to provide the background for important hypothesis-centered research on the safe, effective use of antimicrobials. Beyond the hospital, Guglielmo developed clinical pharmacy services for UCSF's HIV/AIDS program, specifically for the HIV Women's Program and the Men of Color Program.

    Guglielmo has taught doctor of pharmacy students, pharmacy residents and fellows, medical students and residents, and infectious diseases fellows for decades, and has mentored infectious diseases specialty pharmacist residents and fellows continuously since 1986. He has also mentored a number of international scholars, including Fogarty fellows. He is the recipient of many teaching awards, including the UCSF Lifetime Achievement in Mentoring Award, Resident Preceptor of the Year Awards, UCSF School of Pharmacy Long Teaching Awards, and the Academic Senate Distinction in Teaching Award.

    Guglielmo is the long-term editor of Applied Therapeutics: The Clinical Use of Drugs and the Handbook of Applied Therapeutics. He lectures worldwide on the safe, effective use of antimicrobials and other medications. Guglielmo earned a PharmD degree from the University of Southern California in 1978 and completed a pharmacy practice residency at UCSF in 1979, before joining the UCSF School of Pharmacy faculty.


    Collapse Research 
    Collapse Research Activities and Funding
    UCSF-Kaiser Building Interdisciplinary Research Careers in Women's Health Program
    NIH/NICHD K12HD052163Sep 20, 2000 - Jul 31, 2020
    Role: Principal Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000079Dec 1, 1974 - Mar 31, 2009
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Clinical Trials
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Roy SL, Atkins JT, Gennuso R, Kofos D, Sriram RR, Dorlo TP, Hayes T, Qvarnstrom Y, Kucerova Z, Guglielmo B, Visvesvara GS. Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain. Parasitol Res. 2015 Dec; 114(12):4431-9. PMID: 26329128.
      View in: PubMed
    2. Cheng CM, Shin J, Guglielmo B. Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012. JAMA Intern Med. 2014 Oct; 174(10):1704-5. PMID: 25127107.
      View in: PubMed
    3. Hardmeier A, Tsourounis C, Moore M, Abbott WE, Guglielmo B. Pediatric medication administration errors and workflow following implementation of a bar code medication administration system. J Healthc Qual. 2014 Jul-Aug; 36(4):54-61; quiz 61-3. PMID: 25041604.
      View in: PubMed
    4. Gahbauer AM, Gonzales ML, Guglielmo B. Patterns of antibacterial use and impact of age, race/ethnicity, and geographic region on antibacterial use in an outpatient medicaid cohort. Pharmacotherapy. 2014 Jul; 34(7):677-85. PMID: 24753176; PMCID: PMC4082730.
    5. Tan M, Lau J, Guglielmo B. Ethanol locks in the prevention and treatment of catheter-related bloodstream infections. Ann Pharmacother. 2014 May; 48(5):607-15. PMID: 24554477.
      View in: PubMed
    6. Frymoyer A, Guglielmo B, Hersh AL. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections. Pediatr Infect Dis J. 2013 Oct; 32(10):1077-9. PMID: 23652479.
      View in: PubMed
    7. Frymoyer A, Lee S, Bonifacio SL, Meng L, Lucas SS, Guglielmo B, Sun Y, Verotta D. Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. J Perinatol. 2013 Oct; 33(10):778-82. PMID: 23702622; PMCID: PMC3762884.
    8. Gwaza L, Aweeka F, Greenblatt R, Lizak P, Huang L, Guglielmo B. Co-administration of a commonly used Zimbabwean herbal treatment (African potato) does not alter the pharmacokinetics of lopinavir/ritonavir. Int J Infect Dis. 2013 Oct; 17(10):e857-61. PMID: 23587599; PMCID: PMC3776002.
    9. Frymoyer A, Meng L, Bonifacio SL, Verotta D, Guglielmo B. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia. Pharmacotherapy. 2013 Jul; 33(7):718-26. PMID: 23553582; PMCID: PMC3700641.
    10. Burrell C, Tsourounis C, Quan D, Jue V, Tam E, Guglielmo B. Impact of a pharmacist-driven protocol to improve drug allergy documentation at a university hospital. Hosp Pharm. 2013 Apr; 48(4):302-7. PMID: 24421479; PMCID: PMC3839456.
    11. Guglielmo B. The colchicine debacle. JAMA Intern Med. 2013 Feb 11; 173(3):184-5. PMID: 23277277.
      View in: PubMed
    12. Cocohoba JM, Murphy P, Pietrandoni G, Guglielmo B. Improved antiretroviral refill adherence in HIV-focused community pharmacies. J Am Pharm Assoc (2003). 2012 Sep-Oct; 52(5):e67-73. PMID: 23023860; PMCID: PMC4607273.
    13. Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo B. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care STDS. 2012 Sep; 26(9):526-31. PMID: 22860900; PMCID: PMC4088351.
    14. Swartling M, Gupta R, Dudas V, Guglielmo B. Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring. Int J Clin Pharm. 2012 Apr; 34(2):282-5. PMID: 22331444.
      View in: PubMed
    15. Cheng CM, Fu C, Guglielmo B, Auerbach AD. Boxed warning inconsistencies between drug information resources and the prescribing information. Am J Health Syst Pharm. 2011 Sep 01; 68(17):1626-31. PMID: 21856808.
      View in: PubMed
    16. Frymoyer A, Guglielmo B, Wilson SD, Scarpace SB, Benet LZ, Hersh AL. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Pharmacotherapy. 2011 Sep; 31(9):871-6. PMID: 21923588; PMCID: PMC3727161.
    17. Guglielmo B, Edwards DJ, Franks AS, Naughton CA, Schonder KS, Stamm PL, Thornton P, Popovich NG. A critical appraisal of and recommendations for faculty development. Am J Pharm Educ. 2011 Aug 10; 75(6):122. PMID: 21931460; PMCID: PMC3175674.
    18. Meyer-Massetti C, Vaerini S, Rätz Bravo AE, Meier CR, Guglielmo B. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case. Int J Clin Pharm. 2011 Oct; 33(5):806-14. PMID: 21809143.
      View in: PubMed
    19. Cheng C, Guglielmo B. Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling". Arch Intern Med. 2011 May 23; 171(10):946-7. PMID: 21606102.
      View in: PubMed
    20. Meyer-Massetti C, Cheng CM, Schwappach DL, Paulsen L, Ide B, Meier CR, Guglielmo B. Systematic review of medication safety assessment methods. Am J Health Syst Pharm. 2011 Feb 01; 68(3):227-40. PMID: 21258028.
      View in: PubMed
    21. Sohn AH, Schwartz JM, Yang KY, Jarvis WR, Guglielmo B, Weintrub PS. Risk factors and risk adjustment for surgical site infections in pediatric cardiothoracic surgery patients. Am J Infect Control. 2010 Nov; 38(9):706-10. PMID: 20605267.
      View in: PubMed
    22. Macdougall C, Udkow T, Guglielmo B, Vittinghoff E, Martin J. National estimates and predictors of prescription medication sample use in the United States, 1999-2005. J Am Pharm Assoc (2003). 2010 Nov-Dec; 50(6):677-85. PMID: 21071311.
      View in: PubMed
    23. Guglielmo B. A prescription for improved chronic disease management: have community pharmacists function at the top of their training: comment on "Engaging physicians and pharmacists in providing smoking cessation counseling". Arch Intern Med. 2010 Oct 11; 170(18):1646-7. PMID: 20937923.
      View in: PubMed
    24. Cheng CM, Guglielmo B, Maselli J, Auerbach AD. Coverage of FDA medication boxed warnings in commonly used drug information resources. Arch Intern Med. 2010 May 10; 170(9):831-3. PMID: 20458094.
      View in: PubMed
    25. Meyer-Massetti C, Cheng CM, Sharpe BA, Meier CR, Guglielmo B. The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond? J Hosp Med. 2010 Apr; 5(4):E8-16. PMID: 20394022.
      View in: PubMed
    26. Nakamura K, Schwartz BS, Lindegårdh N, Keh C, Guglielmo B. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection. Clin Infect Dis. 2010 Apr 01; 50(7):e47-9. PMID: 20192728.
      View in: PubMed
    27. Koplowicz YB, Schwartz BS, Guglielmo B. Development of daptomycin-susceptible, methicillin-resistant Staphylococcus aureus pneumonia during high-dose daptomycin therapy. Clin Infect Dis. 2009 Oct 15; 49(8):1286-7. PMID: 19780665.
      View in: PubMed
    28. Martin T, Sharma M, Damon L, Kaplan L, Guglielmo B, Working M, O'Malley R, Hwang J, Linker C. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2010 Feb; 12(1):45-50. PMID: 19793068.
      View in: PubMed
    29. Feldman MD, Huang L, Guglielmo B, Jordan R, Kahn J, Creasman JM, Wiener-Kronish JP, Lee KA, Tehrani A, Yaffe K, Brown JS. Training the next generation of research mentors: the University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program. Clin Transl Sci. 2009 Jun; 2(3):216-21. PMID: 19774102.
      View in: PubMed
    30. Frymoyer A, Hersh AL, Benet LZ, Guglielmo B. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J. 2009 May; 28(5):398-402. PMID: 19295465; PMCID: PMC3101254.
    31. Yang K, Zhuo H, Guglielmo B, Wiener-Kronish J. Multidrug-resistant Pseudomonas aeruginosa ventilator-associated pneumonia: the role of endotracheal aspirate surveillance cultures. Ann Pharmacother. 2009 Jan; 43(1):28-35. PMID: 19033484; PMCID: PMC2711849.
    32. Marquez C, Guglielmo B, Klausner JD. Five years later: re-examining the financial burden of boosting with Norvir. AIDS. 2008 Nov 12; 22(17):2402-4. PMID: 18981784.
      View in: PubMed
    33. Patel D, Lawson W, Guglielmo B. Antimicrobial stewardship programs: interventions and associated outcomes. Expert Rev Anti Infect Ther. 2008 Apr; 6(2):209-22. PMID: 18380603.
      View in: PubMed
    34. Frenzel T, Lee CZ, Kim H, Quinnine NJ, Hashimoto T, Lawton MT, Guglielmo B, McCulloch CE, Young WL. Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance. Cerebrovasc Dis. 2008; 25(1-2):157-63. PMID: 18212521; PMCID: PMC2605012.
    35. Schwartz BS, Ngo PD, Guglielmo B. Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis: impact of protein binding? Ann Pharmacother. 2008 Feb; 42(2):289-90. PMID: 18172014.
      View in: PubMed
    36. Robinson CA, Cocohoba J, MacDougall C, John MD, Guglielmo B. Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients. J Am Pharm Assoc (2003). 2007 Sep-Oct; 47(5):613-5. PMID: 17848351.
      View in: PubMed
    37. Yang K, Guglielmo B. Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms. Ann Pharmacother. 2007 Sep; 41(9):1427-35. PMID: 17666573; PMCID: PMC3194036.
    38. Riedel A, Choe L, Inciardi J, Yuen C, Martin T, Guglielmo B. Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study. BMC Infect Dis. 2007 Jul 02; 7:70. PMID: 17605773; PMCID: PMC1925090.
    39. Nicandro JP, Tsourounis C, Frassetto L, Guglielmo B. In vivo effect of I'm-Yunity on hepatic cytochrome P450 3A4. J Herb Pharmacother. 2007; 7(1):39-56. PMID: 17594986.
      View in: PubMed
    40. Huang Y, Okochi H, May BC, Legname G, Prusiner SB, Benet LZ, Guglielmo B, Lin ET. Quinacrine is mainly metabolized to mono-desethyl quinacrine by CYP3A4/5 and its brain accumulation is limited by P-glycoprotein. Drug Metab Dispos. 2006 Jul; 34(7):1136-44. PMID: 16581945.
      View in: PubMed
    41. Schuster FL, Guglielmo B, Visvesvara GS. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J Eukaryot Microbiol. 2006 Mar-Apr; 53(2):121-6. PMID: 16579814.
      View in: PubMed
    42. Deck DH, Guglielmo B. Pharmacological advances in the treatment of invasive candidiasis. Expert Rev Anti Infect Ther. 2006 Feb; 4(1):137-49. PMID: 16441215.
      View in: PubMed
    43. Lee CZ, Yao JS, Huang Y, Zhai W, Liu W, Guglielmo B, Lin E, Yang GY, Young WL. Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation. J Cereb Blood Flow Metab. 2006 Sep; 26(9):1157-64. PMID: 16395286.
      View in: PubMed
    44. Mendez MN, Gibbs L, Jacobs RA, McCulloch CE, Winston L, Guglielmo B. Impact of a piperacillin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin-resistant enterococci and Clostridium difficile infections. Pharmacotherapy. 2006 Jan; 26(1):61-7. PMID: 16509027.
      View in: PubMed
    45. Guglielmo B, Dudas V, Maewal I, Young R, Hilts A, Villmann M, Gibbs L, Gropper M, Jacobs R. Impact of a series of interventions in vancomycin prescribing on use and prevalence of vancomycin-resistant enterococci. Jt Comm J Qual Patient Saf. 2005 Aug; 31(8):469-75. PMID: 16156195.
      View in: PubMed
    46. MacDougall C, Guglielmo B, Maselli J, Gonzales R. Antimicrobial drug prescribing for pneumonia in ambulatory care. Emerg Infect Dis. 2005 Mar; 11(3):380-4. PMID: 15757551; PMCID: PMC3298265.
    47. Chang NN, Murray CK, Houck PM, Bratzler DW, Greenway C, Guglielmo B. Blood culture and susceptibility results and allergy history do not influence fluoroquinolone use in the treatment of community-acquired pneumonia. Pharmacotherapy. 2005 Jan; 25(1):59-66. PMID: 15767221.
      View in: PubMed
    48. Yung L, Huang Y, Lessard P, Legname G, Lin ET, Baldwin M, Prusiner SB, Ryou C, Guglielmo B. Pharmacokinetics of quinacrine in the treatment of prion disease. BMC Infect Dis. 2004 Nov 29; 4:53. PMID: 15569390; PMCID: PMC535929.
    49. Killgore KM, March KL, Guglielmo B. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother. 2004 Jul-Aug; 38(7-8):1148-52. PMID: 15150380.
      View in: PubMed
    50. MacDougall C, Guglielmo B. Pharmacokinetics of valaciclovir. J Antimicrob Chemother. 2004 Jun; 53(6):899-901. PMID: 15140857.
      View in: PubMed
    51. Bower AN, Tang HM, Guglielmo B. Compliance in two medical centers with criteria for use of caspofungin and lipid-based amphotericin B. Am J Health Syst Pharm. 2004 May 01; 61(9):915-20. PMID: 15156967.
      View in: PubMed
    52. Oren E, Shaffer ER, Guglielmo B. Impact of emerging technologies on medication errors and adverse drug events. Am J Health Syst Pharm. 2003 Jul 15; 60(14):1447-58. PMID: 12892029.
      View in: PubMed
    53. Phan DD, Chin-Hong P, Lin ET, Anderle P, Sadee W, Guglielmo B. Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor. Antimicrob Agents Chemother. 2003 Jul; 47(7):2351-3. PMID: 12821497; PMCID: PMC161865.
    54. Hickman DE, Stebbins MR, Hanak JR, Guglielmo B. Pharmacy-based intervention to reduce antibiotic use for acute bronchitis. Ann Pharmacother. 2003 Feb; 37(2):187-91. PMID: 12549944.
      View in: PubMed
    55. Oren E, Griffiths LP, Guglielmo B. Characteristics of antimicrobial overrides associated with automated dispensing machines. Am J Health Syst Pharm. 2002 Aug 01; 59(15):1445-8. PMID: 12166045.
      View in: PubMed
    56. Yang K, Guglielmo B. Patient education for H pylori: who benefits? West J Med. 2002 Mar; 176(2):97. PMID: 11897729; PMCID: PMC1071674.
    57. Graff LR, Franklin KK, Witt L, Cohen N, Jacobs RA, Tompkins L, Guglielmo B. Antimicrobial therapy of gram-negative bacteremia at two university-affiliated medical centers. Am J Med. 2002 Feb 15; 112(3):204-11. PMID: 11893347.
      View in: PubMed
    58. Botwin KJ, Chan J, Jacobs R, Guglielmo B. Restricted access to automated dispensing machines for surgical antimicrobial prophylaxis. Am J Health Syst Pharm. 2001 May 01; 58(9):797-9. PMID: 11351920.
      View in: PubMed
    59. Burkiewicz JS, Kostiuk KA, Jacobs RA, Guglielmo B. Impact of an intravenous fluconazole restriction policy on patient outcomes. Ann Pharmacother. 2001 Jan; 35(1):9-13. PMID: 11197590.
      View in: PubMed
    60. Dudas V, Hopefl A, Jacobs R, Guglielmo B. Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals. Ann Pharmacother. 2000 Apr; 34(4):446-52. PMID: 10772428.
      View in: PubMed
    61. Guglielmo B, Luber AD, Paletta D, Jacobs RA. Ceftriaxone therapy for staphylococcal osteomyelitis: a review. Clin Infect Dis. 2000 Jan; 30(1):205-7. PMID: 10619757.
      View in: PubMed
    62. Guglielmo B, Luber AD, Corelli RL, Flaherty JF, Jacobs RA. Prevention of adverse events in hospitalized patients using an antimicrobial review program. West J Med. 1999 Sep; 171(3):159-62. PMID: 10560287; PMCID: PMC1305797.
    63. Luber AD, Maa L, Lam M, Guglielmo B. Risk factors for amphotericin B-induced nephrotoxicity. J Antimicrob Chemother. 1999 Feb; 43(2):267-71. PMID: 11252333.
      View in: PubMed
    64. Guglielmo B. Use of antimicrobial agents in patients with cardiovascular disease. J Cardiovasc Nurs. 1999 Jan; 13(2):23-30. PMID: 9888061.
      View in: PubMed
    65. Wong-Beringer A, Jacobs RA, Guglielmo B. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis. 1998 Sep; 27(3):603-18. PMID: 9770163.
      View in: PubMed
    66. Guglielmo B, Kostiuk KA, Pons VG. Pharmacokinetics and pharmacodynamics of ceftizoxime in abscess fluid. J Antimicrob Chemother. 1997 Mar; 39(3):437-8. PMID: 9096200.
      View in: PubMed
    67. Barlows TG, Luber AD, Jacobs RA, Guglielmo B. Hypothermia following the intravenous administration of amphotericin B. Clin Infect Dis. 1996 Nov; 23(5):1187-8. PMID: 8922832.
      View in: PubMed
    68. Hashimoto S, Wolfe E, Guglielmo B, Shanks R, Sundelof J, Pittet JF, Thomas E, Wiener-Kronish J. Aerosolization of imipenem/cilastatin prevents pseudomonas-induced acute lung injury. J Antimicrob Chemother. 1996 Nov; 38(5):809-18. PMID: 8961050.
      View in: PubMed
    69. Tsourounis C, Guglielmo B. Aerosolized amphotericin B in prophylaxis of pulmonary aspergillosis. Ann Pharmacother. 1996 Oct; 30(10):1175-6. PMID: 8893125.
      View in: PubMed
    70. Guglielmo B, Jacobs RA. Impact of dosage-monitoring system on frequency of seizures associated with imipenem-cilastatin. Am J Health Syst Pharm. 1996 Sep 1; 53(17):2097-8. PMID: 8870902.
      View in: PubMed
    71. Guglielmo B, Quan LA, Stulbarg MS. Pharmacokinetics of once-daily versus thrice daily tobramycin in cystic fibrosis patients. J Antimicrob Chemother. 1996 May; 37(5):1040-2. PMID: 8737161.
      View in: PubMed
    72. Luber AD, Jacobs RA, Jordan M, Guglielmo B. Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci. J Infect Dis. 1996 May; 173(5):1292-4. PMID: 8627091.
      View in: PubMed
    73. Guglielmo B. Practical strategies for the appropriate use of antimicrobials. Pharm World Sci. 1995 Jul 28; 17(4):96-102. PMID: 7581222.
      View in: PubMed
    74. Wong-Beringer A, Corelli RL, Schrock TR, Guglielmo B. Influence of timing of antibiotic administration on tissue concentrations during surgery. Am J Surg. 1995 Apr; 169(4):379-81. PMID: 7694975.
      View in: PubMed
    75. Singh RF, Corelli RL, Guglielmo B. Sterility of unit dose syringes of filgrastim and sargramostim. Am J Hosp Pharm. 1994 Nov 15; 51(22):2811-2. PMID: 7531941.
      View in: PubMed
    76. Kostiuk KA, Pons VG, Guglielmo B. Penetration of fluconazole into abscess fluid. J Antimicrob Chemother. 1994 Oct; 34(4):603-5. PMID: 7868415.
      View in: PubMed
    77. Guglielmo B, Wong-Beringer A, Linker CA. Immune globulin therapy in allogeneic bone marrow transplant: a critical review. Bone Marrow Transplant. 1994 May; 13(5):499-510. PMID: 8054903.
      View in: PubMed
    78. Joe LA, Jacobs RA, Guglielmo B. Systemic absorption of oral fluconazole after gastrointestinal resection. J Antimicrob Chemother. 1994 May; 33(5):1070. PMID: 8089060.
      View in: PubMed
    79. Kanatani MS, Guglielmo B. The new macrolides. Azithromycin and clarithromycin. West J Med. 1994 Jan; 160(1):31-7. PMID: 8128699; PMCID: PMC1022251.
    80. Wong-Beringer A, Jacobs RA, Guglielmo B. Nosocomial funguria: resultant morbidity and therapeutic intervention. Clin Infect Dis. 1993 Dec; 17(6):1066-7. PMID: 8110936.
      View in: PubMed
    81. Pons VG, Denlinger SL, Guglielmo B, Octavio J, Flaherty J, Derish PA, Wilson CB. Ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis: a randomized, prospective, blinded clinical study. Neurosurgery. 1993 Sep; 33(3):416-22; discussion 422-3. PMID: 8413872.
      View in: PubMed
    82. Pons VG, Denlinger SL, Guglielmo B, Octavio J, Flaherty J, Derish PA, Wilson CB. Comment; ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis. Neurosurgery. 1993 Sep; 33(3):537. PMID: 8413895.
      View in: PubMed
    83. Colford JM, Corelli RL, Ganz JW, Guglielmo B, Jacobs RA. Home antibiotic therapy for streptococcal endocarditis: a call for a controlled trial. Am J Med. 1993 Jan; 94(1):111-2. PMID: 8420289.
      View in: PubMed
    84. Wong-Beringer A, Jacobs RA, Guglielmo B. Treatment of funguria. JAMA. 1992 May 27; 267(20):2780-5. PMID: 1578598.
      View in: PubMed
    85. Barriere SL, Guglielmo B. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies. Clin Pharm. 1992 Mar; 11(3):223-35. PMID: 1611812.
      View in: PubMed
    86. Corelli RL, Guglielmo B, Kapusnik-Uner JE, McMaster JR, Greenblatt RM. Medication usage patterns in patients with human immunodeficiency virus infection: a comparison of patient-reported medication usage with medical chart review. DICP. 1991 Dec; 25(12):1374-8. PMID: 1815436.
      View in: PubMed
    87. Glick PL, Guglielmo B, Winter ME, Finkbeiner W, Turley K. Iodine toxicity secondary to continuous povidone-iodine mediastinal irrigation in dogs. J Surg Res. 1990 Nov; 49(5):428-34. PMID: 2246887.
      View in: PubMed
    88. Glick M, Guglielmo B. Antibiotic prophylaxis in cesarean section. DICP. 1990 Sep; 24(9):841-6. PMID: 2260343.
      View in: PubMed
    89. Hebert MF, Guglielmo B. What is the clinical role of aerosolized ribavirin? DICP. 1990 Jul-Aug; 24(7-8):735-8. PMID: 2197815.
      View in: PubMed
    90. Brodowy BA, Guglielmo B, York MK, Herfindal ET, Brooks GF. Experience with selective reporting of susceptibility to antimicrobial agents. Am J Hosp Pharm. 1989 Sep; 46(9):1816-8. PMID: 2801717.
      View in: PubMed
    91. Tam J, Guglielmo B. Microbiology and antibiotics in infectious abdominal emergencies. Emerg Med Clin North Am. 1989 Aug; 7(3):611-29. PMID: 2663459.
      View in: PubMed
    92. Guglielmo B, Schweigert BF, Kishi DT. Pharmacist-managed drug therapy in California hospitals. Am J Hosp Pharm. 1989 Jul; 46(7):1366-9. PMID: 2757041.
      View in: PubMed
    93. Oliva SL, Guglielmo B, Jacobs R, Pons VG. Failure of intravenous vancomycin and intravenous metronidazole to prevent or treat antibiotic-associated pseudomembranous colitis. J Infect Dis. 1989 Jun; 159(6):1154-5. PMID: 2491408.
      View in: PubMed
    94. Sue D, Salazar TA, Turley K, Guglielmo B. Effect of surgical blood loss and volume replacement on antibiotic pharmacokinetics. Ann Thorac Surg. 1989 Jun; 47(6):857-9. PMID: 2757440.
      View in: PubMed
    95. Guglielmo B, Jacobs RA, Locksley RM. The exposure of health care workers to ribavirin aerosol. JAMA. 1989 Apr 07; 261(13):1880-1. PMID: 2926922.
      View in: PubMed
    96. Guglielmo B, Salazar TA, Rodondi LC, Carver M, Goldstone J, Stoney RJ. Altered pharmacokinetics of antibiotics during vascular surgery. Am J Surg. 1989 Apr; 157(4):410-2. PMID: 2929864.
      View in: PubMed
    97. Dugoni BM, Guglielmo B, Hollander H. Amphotericin B concentration in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis. Clin Pharm. 1989 Mar; 8(3):220-1. PMID: 2706895.
      View in: PubMed
    98. Flaherty JF, Rodondi LC, Guglielmo B, Fleishaker JC, Townsend RJ, Gambertoglio JG. Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens. Antimicrob Agents Chemother. 1988 Dec; 32(12):1825-9. PMID: 3245695; PMCID: PMC176026.
    99. Guglielmo B, Rodondi LC. Comparison of antibiotic activities by using serum bactericidal activity over time. Antimicrob Agents Chemother. 1988 Oct; 32(10):1511-4. PMID: 3056237; PMCID: PMC175909.
    100. Lam YW, Duroux MH, Gambertoglio JG, Barriere SL, Guglielmo B. Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteers. Antimicrob Agents Chemother. 1988 Mar; 32(3):298-302. PMID: 3284457; PMCID: PMC172163.
    101. Arnold PA, Guglielmo B, Hollander H. Severe hypersensitivity reaction upon rechallenge with trimethoprim-sulfamethoxazole in a patient with AIDS. Drug Intell Clin Pharm. 1988 Jan; 22(1):43-5. PMID: 2965002.
      View in: PubMed
    102. Guglielmo B, Flaherty JF, Woods TM, LaFollette G, Gambertoglio JG. Pharmacokinetics of cefoperazone and tobramycin alone and in combination. Antimicrob Agents Chemother. 1987 Feb; 31(2):264-6. PMID: 3566252; PMCID: PMC174703.
    103. Guglielmo B, Flaherty JF, Batman R, Barriere SL, Gambertoglio JG. Comparative pharmacokinetics of low- and high-dose ticarcillin. Antimicrob Agents Chemother. 1986 Sep; 30(3):359-60. PMID: 3777901; PMCID: PMC180559.
    104. Glick PL, Guglielmo B, Tranbaugh RF, Turley K. Iodine toxicity in a patient treated by continuous povidone-iodine mediastinal irrigation. Ann Thorac Surg. 1985 May; 39(5):478-80. PMID: 3994451.
      View in: PubMed
    105. Guglielmo B, Hohn DC, Koo PJ, Hunt TK, Sweet RL, Conte JE. Antibiotic prophylaxis in surgical procedures. A critical analysis of the literature. Arch Surg. 1983 Aug; 118(8):943-55. PMID: 6347124.
      View in: PubMed
    106. Kehoe WA, Guglielmo B. Excessive potassium depletion with metolazone and furosemide. Clin Pharm. 1983 Jul-Aug; 2(4):304-5. PMID: 6883959.
      View in: PubMed
    107. Quart BD, Guglielmo B. Prolonged diarrhea secondary to methyldopa therapy. Drug Intell Clin Pharm. 1983 Jun; 17(6):462. PMID: 6861636.
      View in: PubMed
    108. Brown KR, Guglielmo B, Pons VG, Jacobs RA. Theophylline elixir, moxalactam, and a disulfiram reaction. Ann Intern Med. 1982 Oct; 97(4):621-2. PMID: 6214982.
      View in: PubMed
    B. Joseph's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP